According to the research report titled ‘Global Coagulation Analyzer Market Size study, by Product (Clinical Laboratory, consumables, reagents, PoCT, Manual, Automated), Test (Prothrombin Time Testing (PT), Fibrinogen, APTT, Activated Clotting Time Testing (ACT), Activated Partial Thromboplastin Time Testing, D Dimer, Platelet Function Tests, Anti-Factor XA Tests, Heparin & Protamine Dose-response Tests for ACT, Other Coagulation Tests), Technology (Optical, Mechanical, Electrochemical) End User (Clinical Labs, Hospitals) and Regional Forecasts 2020-2027’, available with Market Study Report, global coagulation analyzer market was worth USD 3.03 billion in 2019 and is anticipated to record a y-o-y growth rate of 5.7% during 2020-2027.

Adoption of sedentary lifestyle leading to obesity, deficiency of vitamin K, and smoking, along with increasing cases of blood clotting disorders are primarily driving the growth of global coagulation analyzer market.

Notably, coagulation analyzers help measure the blood platelet levels, with clotting test being utilized for hemostasis system diagnosis and new coagulometers are used to observe blood clots and blood plasma expansion in blood.

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2854759/

Surging population suffering from cardiovascular diseases, chronic blood disorders, and lifestyle diseases is further augmenting global coagulation analyzer market size. According to American Heart Association annual statistics published in January 2019, 48% of U.S. adults were suffering from some form of cardiovascular disease.

Moreover, rising cognizance regarding different health conditions is anticipated to boost the diagnostic rate and preventive care management, which will further fuel the testing volume, facilitating the business scenario. In addition, the product demand is backed by expansion of diagnostic centers and clinical laboratories on account of escalating number of patients with blood clots.

Despite the promising profit trajectory of global coagulation analyzer industry, factors such as stringent government regulations, and hefty cost will negatively impact business expansion over the estimated timeframe.

Citing the geographical spectrum, prominent regions considered for worldwide coagulation analyzer market analysis are Asia Pacific, Europe, Latin America, North America, and Rest of the World. North America currently dominates the overall market and is likely to depict a similar trend in the upcoming years, owing to well-established healthcare infrastructure and increasing number of clinics and hospitals in the region.

On the other hand, Asia Pacific coagulation analyzer industry is expected to record a robust growth through 2026, on account of increasing pervasiveness of cardiovascular diseases as well as other chronic disorders, in consort with growing population.

Well-established firms in global coagulation analyzer market are Bio Group Medical System S.R.L., Maccura Biotechnology Co. Ltd., Roche Diagnostics International AG, Nihon Kohden Corporation, Horiba Ltd., Thermo Fisher Scientific Inc., Sysmex Corporation, Siemens Healthineers AG, Danaher Corporation, and Abbott Laboratories.